Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Targacept Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that it will report financial results for the second quarter of 2013 on Tuesday, August 6, 2013, before the U.S. financial markets open.
Hey, check out all the research scientist jobs. Post your resume today!
